TNFRSF11A and chronic obstructive pulmonary disease: This suggests that systemic OPG is not a biomarker of increased generalised inflammation and is not a useful tool for risk prediction in patients with acute exacerbation of COPD, although the OPG/RANKL/RANK system might be regulated in COPD [16].